 Diabetes is a global epidemic with rising rates of prevalence in both developed and developing nations. Glycated hemoglobin HbA1c, which measures the average level of sugar in the blood over the past few months, can be used as a reliable alternative to fasting blood glucose levels for diagnosing diabetes. It is also associated with increased risks of cardiovascular diseases and strokes, making it an important biomarker for assessing the health of diabetic patients. This article was authored by Shariq Aysherwani, Asiba Aikong, Aysher Aiksemi, and others.